PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.92%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.61B
AUM Growth
+$2.61B
(+2.1%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
32.6%
Holding
88
New
10
Increased
24
Reduced
13
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$37.2M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$34.9M |
| 3 |
Penumbra
PEN
|
$33.6M |
| 4 |
HCA Healthcare
HCA
|
$32.2M |
| 5 |
Prothena Corp
PRTA
|
$30M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$78M |
| 2 |
Pfizer
PFE
|
$70.4M |
| 3 |
Merck
MRK
|
$52.7M |
| 4 |
Becton Dickinson
BDX
|
$32.2M |
| 5 |
Universal Health Services
UHS
|
$32M |
Sector Composition
| 1 | Healthcare | 93.65% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Edwards Lifesciences
EW
$47.8B
| $39.7M | 1.44% | 480,256 +142,101 | +42% | +$11.7M |
|
27
Cigna
CI
$80.3B
| $39.2M | 1.42% | 141,300 | – | – |
|
|
28
Biogen
BIIB
$19.4B
| $37.2M | 1.35% | +139,326 | New | +$37.2M |
|
29
argenx
ARGX
$43.6B
| $37M | 1.34% | 104,732 | – | – |
|
30
McKesson
MCK
$85.4B
| $36M | 1.3% | 105,811 | – | – |
|
|
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $34.9M | 1.26% | +4,515,216 | New | +$34.9M |
|
32
Veeva Systems
VEEV
$44B
| $33.4M | 1.21% | 202,387 | – | – |
|
|
33
HCA Healthcare
HCA
$94.5B
| $32.2M | 1.17% | +175,235 | New | +$32.2M |
|
34
Waters Corp
WAT
$18B
| $31.7M | 1.15% | 117,634 | – | – |
|
35
AstraZeneca
AZN
$248B
| $31.6M | 1.14% | 576,800 | – | – |
|
36
Thermo Fisher Scientific
TMO
$186B
| $31.5M | 1.14% | 62,143 | – | – |
|
|
37
Merck
MRK
$210B
| $31M | 1.12% | 360,520 -611,478 | -63% | -$52.7M |
|
38
Syndax Pharmaceuticals
SNDX
$1.41B
| $31M | 1.12% | 1,289,073 +708,305 | +122% | +$17M |
|
|
KRTX
39
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $29.3M | 1.06% | 130,293 | – | – |
|
40
Tenet Healthcare
THC
$16.3B
| $28.1M | 1.02% | 544,583 | – | – |
|
41
BioCryst Pharmaceuticals
BCRX
$1.74B
| $27.2M | 0.99% | 2,162,411 | – | – |
|
|
NVRO
42
DELISTED
NEVRO CORP.
NVRO
| $26.3M | 0.95% | 563,560 -95,850 | -15% | -$4.47M |
|
43
Icon
ICLR
$13.8B
| $24.8M | 0.9% | 134,740 -23,443 | -15% | -$4.31M |
|
44
ICU Medical
ICUI
$3.15B
| $24.1M | 0.87% | 160,250 -81,935 | -34% | -$12.3M |
|
|
45
Johnson & Johnson
JNJ
$427B
| $22.5M | 0.81% | 137,746 -477,318 | -78% | -$78M |
|
46
Procept Biorobotics
PRCT
$2.23B
| $21.5M | 0.78% | 517,526 +160,034 | +45% | +$6.64M |
|
47
Intellia Therapeutics
NTLA
$1.22B
| $19.3M | 0.7% | 344,868 +181,588 | +111% | +$10.2M |
|
|
OSH
48
DELISTED
Oak Street Health, Inc.
OSH
| $17.7M | 0.64% | 722,844 +104,083 | +17% | +$2.55M |
|
49
Generation Bio
GBIO
$40.4M
| $16M | 0.58% | 3,013,712 +240,399 | +9% | +$1.28M |
|
50
Editas Medicine
EDIT
$231M
| $15.7M | 0.57% | 1,279,054 +649,370 | +103% | +$7.95M |
|